These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9853191)

  • 1. The effects of norepinephrine on myocardial biology: implications for the therapy of heart failure.
    Colucci WS
    Clin Cardiol; 1998 Dec; 21(12 Suppl 1):I20-4. PubMed ID: 9853191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenergic overload and apoptosis in heart failure: implications for therapy.
    Colucci WS; Sawyer DB; Singh K; Communal C
    J Card Fail; 2000 Jun; 6(2 Suppl 1):1-7. PubMed ID: 10908092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic rationale for the use of beta-blockers in the treatment of heart failure.
    Sabbah HN
    Heart Fail Rev; 2004 Apr; 9(2):91-7. PubMed ID: 15516856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nervous system in heart failure.
    Cohn JN
    Circulation; 2002 Nov; 106(19):2417-8. PubMed ID: 12417535
    [No Abstract]   [Full Text] [Related]  

  • 6. [State of the sympathetic-adrenal system in congestive cardiac insufficiency].
    Korochkin IM; Oganov RG
    Kardiologiia; 1973 Mar; 13(3):140-51. PubMed ID: 4149940
    [No Abstract]   [Full Text] [Related]  

  • 7. Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.
    Machackova J; Sanganalmath SK; Barta J; Dhalla KS; Dhalla NS
    Cardiovasc Toxicol; 2010 Mar; 10(1):9-16. PubMed ID: 19949891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker therapy in heart failure.
    Carson P
    Cardiol Clin; 2001 May; 19(2):267-78, vi. PubMed ID: 11407109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic regulation of myocardial apoptosis.
    Singh K; Communal C; Sawyer DB; Colucci WS
    Cardiovasc Res; 2000 Feb; 45(3):713-9. PubMed ID: 10728393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of sympathetic endothelin A receptors for adverse cardiac remodeling.
    Lehmann LH; Rostosky JS; Buss SJ; Kreusser MM; Krebs J; Mier W; Enseleit F; Spiger K; Hardt SE; Wieland T; Haass M; Lüscher TF; Schneider MD; Parlato R; Gröne HJ; Haberkorn U; Yanagisawa M; Katus HA; Backs J
    Proc Natl Acad Sci U S A; 2014 Sep; 111(37):13499-504. PubMed ID: 25197047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers in heart failure.
    Cohn JN
    Eur Heart J; 1998 Jun; 19 Suppl F():F52-5. PubMed ID: 9651736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
    Newton GE; Parker JD
    Circulation; 1996 Aug; 94(3):353-8. PubMed ID: 8759076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
    Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
    Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for beta-adrenergic blocking drugs in cardiomyopathy.
    Fowler MB; Bristow MR
    Am J Cardiol; 1985 Apr; 55(10):120D-124D. PubMed ID: 2859789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic activation and the role of beta-blockers in chronic heart failure.
    Krum H
    Aust N Z J Med; 1999 Jun; 29(3):418-27. PubMed ID: 10868514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and cellular mechanisms of myocardial failure.
    Colucci WS
    Am J Cardiol; 1997 Dec; 80(11A):15L-25L. PubMed ID: 9412539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
    Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Icariin attenuates cardiac remodelling through down-regulating myocardial apoptosis and matrix metalloproteinase activity in rats with congestive heart failure.
    Song YH; Cai H; Gu N; Qian CF; Cao SP; Zhao ZM
    J Pharm Pharmacol; 2011 Apr; 63(4):541-9. PubMed ID: 21401606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical therapy of chronic heart failure. Role of ACE inhibitors and beta-blockers.
    Eichhorn EJ
    Cardiol Clin; 1998 Nov; 16(4):711-25, ix. PubMed ID: 9891599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M; Machida N; Mitsuishi M; Yamane Y
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.